Evidence map›Paper›PMID 41513722›Full record

ArticleScientific reports2026

Medical support platform for melanoma analysis and detection based on federated learning.

Sergio Laso, Juan Luis Herrera, Daniel Flores-Martin

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sergio Laso *Dept. of Computer Systems and Telematics Engineering, Universidad de Extremadura, Cáceres, Spain. slasom@unex.es.
Juan Luis Herrera *Distributed Systems Group, TU Wien, Vienna, Austria.
Daniel Flores-Martin *COMPUTAEX. Extremadura Supercomputing Center, Cáceres, Spain.

Funding

Department of Education, Science and Professional Training of the Government of Extremadura GR24099European Union under the MSCA project RENOS Contract number 101205037MICIU/AEI/10.13039/50100011033 and the "European Union NextGenerationEU/PRTR" DIN2020-011586
6 · The paper itself

Abstract

Advances in computer science and medicine have led to the emergence of artificial intelligence as a key tool in the medical and scientific fields. Its application in the diagnosis and treatment of diseases, such as cancer, has proven to be fundamental in improving early detection and saving lives. This article presents a proposal based on Deep Learning to develop a model capable of detecting melanomas in the skin from clinical images. The aim is to provide doctors with a tool to support early identification of this type of cancer, considering additional factors such as sun exposure and the patient's skin tone. To optimize diagnostic accuracy and prevent data silos, a collaborative learning technique called Federated Learning is implemented. The FL framework employs a weighted averaging algorithm for model aggregation, allowing locally trained models to contribute to a continuously improving global model without sharing patient data. Experiments show that the proposed federated model achieved an accuracy of 89.1% and a ROC AUC of 0.9251, demonstrating performance comparable to centralized training while preserving privacy. In addition, a web application is presented to manage and process the information efficiently, making it easier for doctors to consult and analyze the results.

Indexed as

MelanomaSkin NeoplasmsAlgorithmsDeep LearningFederated LearningHumanseHealthFederated LearningMelanoma

Identifiers

PMID41513722
PMCPMC12820230

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.